These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pooled comparison of regadenoson versus adenosine for measuring fractional flow reserve and coronary flow in the catheterization laboratory. Stolker JM; Lim MJ; Shavelle DM; Morris DL; Angiolillo DJ; Guzman LA; Kennedy KF; Weber E; Zareh M; Neumayr RH; Zenni MM Cardiovasc Revasc Med; 2015; 16(5):266-71. PubMed ID: 26242981 [TBL] [Abstract][Full Text] [Related]
5. Single bolus intravenous regadenoson injection versus central venous infusion of adenosine for maximum coronary hyperaemia in fractional flow reserve measurement. van Nunen LX; Lenders GD; Schampaert S; van 't Veer M; Wijnbergen I; Brueren GR; Tonino PA; Pijls NH EuroIntervention; 2015 Dec; 11(8):905-13. PubMed ID: 25136887 [TBL] [Abstract][Full Text] [Related]
6. Comparison of regadenoson and nitroprusside to adenosine for measurement of fractional flow reserve: A systematic review and meta-analysis. Lee JZ; Singh N; Nyotowidjojo I; Howe C; Low SW; Nguyen T; Pinto D; Kumar G; Lee KS Cardiovasc Revasc Med; 2018 Mar; 19(2):168-174. PubMed ID: 28888873 [TBL] [Abstract][Full Text] [Related]
7. Intravenous regadenoson with aminophylline reversal is safe and equivalent to intravenous adenosine infusion for fractional flow reserve measurements. Edward JA; Lee JH; White CJ; Morin DP; Bober R Clin Cardiol; 2018 Oct; 41(10):1348-1352. PubMed ID: 30125368 [TBL] [Abstract][Full Text] [Related]
8. Variability of fractional flow reserve according to the methods of hyperemia induction. Lim WH; Koo BK; Nam CW; Doh JH; Park JJ; Yang HM; Park KW; Kim HS; Takashima H; Waseda K; Amano T; Kato D; Kurita A; Oi M; Toyofuku M; van Nunen L; Pijls NH Catheter Cardiovasc Interv; 2015 May; 85(6):970-6. PubMed ID: 25413590 [TBL] [Abstract][Full Text] [Related]
9. [Regadenoson as a new stress agent in myocardial perfusion imaging. Initial experience in The Netherlands]. Jager PL; Buiting M; Mouden M; Oostdijk AH; Timmer J; Knollema S Rev Esp Med Nucl Imagen Mol; 2014; 33(6):346-51. PubMed ID: 24862658 [TBL] [Abstract][Full Text] [Related]
11. Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics. Mekkaoui C; Jadbabaie F; Dione DP; Meoli DF; Purushothaman K; Belardinelli L; Sinusas AJ JACC Cardiovasc Imaging; 2009 Oct; 2(10):1198-208. PubMed ID: 19833310 [TBL] [Abstract][Full Text] [Related]
12. Comparison of efficacy and safety of intracoronary sodium nitroprusside and intravenous adenosine for assessing fractional flow reserve. Rudzinski W; Waller AH; Rusovici A; Dehnee A; Nasur A; Benz M; Sanchez S; Klapholz M; Kaluski E Catheter Cardiovasc Interv; 2013 Feb; 81(3):540-4. PubMed ID: 22961876 [TBL] [Abstract][Full Text] [Related]
13. Feasibility, safety and effectiveness in measuring microvascular resistance with regadenoson. Lachmann V; Heimann M; Jung C; Zeus T; Verde PE; Kelm M; Bönner F Clin Hemorheol Microcirc; 2019; 71(3):299-310. PubMed ID: 30103305 [TBL] [Abstract][Full Text] [Related]
14. Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve? Casella G; Leibig M; Schiele TM; Schrepf R; Seelig V; Stempfle HU; Erdin P; Rieber J; König A; Siebert U; Klauss V Am Heart J; 2004 Oct; 148(4):590-5. PubMed ID: 15459587 [TBL] [Abstract][Full Text] [Related]
15. Regadenoson: review of its established role in myocardial perfusion imaging and emerging applications. Palani G; Ananthasubramaniam K Cardiol Rev; 2013; 21(1):42-8. PubMed ID: 22643345 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the Safety of Adenosine and Regadenoson in Patients Undergoing Outpatient Cardiac Stress Testing. Brink HL; Dickerson JA; Stephens JA; Pickworth KK Pharmacotherapy; 2015 Dec; 35(12):1117-23. PubMed ID: 26684552 [TBL] [Abstract][Full Text] [Related]
17. Comparison of intracoronary versus intravenous administration of adenosine for measurement of coronary fractional flow reserve. Schlundt C; Bietau C; Klinghammer L; Wiedemann R; Rittger H; Ludwig J; Achenbach S Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25908694 [TBL] [Abstract][Full Text] [Related]
18. Advances in pharmacologic stress agents: focus on regadenoson. Johnson SG; Peters S J Nucl Med Technol; 2010 Sep; 38(3):163-71. PubMed ID: 20724531 [TBL] [Abstract][Full Text] [Related]
19. Effects of increasing doses of intracoronary adenosine on the assessment of fractional flow reserve. De Luca G; Venegoni L; Iorio S; Giuliani L; Marino P JACC Cardiovasc Interv; 2011 Oct; 4(10):1079-84. PubMed ID: 22017932 [TBL] [Abstract][Full Text] [Related]